Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Succinamide derivatives for inhibiting MMPs and/or TNF production

March 6, 1998

New antiinflammatory and analgesic compounds in development at Roche

March 5, 1998

Idec, SKB announce development plans for clenoliximab

March 3, 1998

Boehringer Ingelheim reveals new antiinflammatory agents

March 3, 1998

AutoImmune will conduct pivotal study of Colloral

Feb. 27, 1998

Beneficial effects of FK-506 in animal model of rheumatoid arthritis

Feb. 27, 1998

Orthovisc PMA accepted for filing by FDA

Feb. 25, 1998

Selective inhibitor of p38 MAP kinase effective in chronic inflammatory diseases

Feb. 25, 1998

Flobufen update

Feb. 24, 1998

First phase II results reported for EuroAlliance's DAAID

Feb. 23, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...